Oppenheimer reiterates Outperform rating on Tyra Biosciences; $40 target
Oppenheimer reiterated an Outperform rating on Tyra Biosciences and set a $40.00 price target, implying 55.9% upside versus the Sep 21 close of $25.65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.